NASDAQ:MYGN

Myriad Genetics Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy MYGN

*Your capital is at risk

$2.86

-2.51 (-46.74%)

At Close: Jul 31, 2026

Myriad Genetics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 83.95. In total, the insiders bought 4.32M and sold 291.31K MYGN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	83.95
● Buy	4.32M shares
● Sell	291.31K shares
58% Buy Activity Strong Negative Correlation
Buy Signal Medium Confidence Mar 12, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 83.95. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 01, 2026 Sell	Common Stock F-InKind	Solaiman Shereen Chief People Officer	Officer	1 675 Value: $8K
Feb 27, 2026 Buy	Common Stock P-Purchase	Phanstiel S. Louise Director	Director	48 000 Value: $223.7K
Feb 26, 2026 Buy	Common Stock P-Purchase	Phanstiel S. Louise Director	Director	50 407 Value: $242.1K
Feb 25, 2026 Buy	Common Stock P-Purchase	Phanstiel S. Louise Director	Director	6 100 Value: $28.9K
Feb 02, 2026 Buy	Common Stock A-Award	Muzzey Dale Chief Scientific Officer	Officer	23 697 Value: $129.6K
Feb 02, 2026 Buy	Common Stock A-Award	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	4 994 Value: $27.3K
Feb 02, 2026 Buy	Common Stock A-Award	Verratti Mark Chief Operating Officer	C-Suite Officer	32 810 Value: $179.5K
Feb 02, 2026 Buy	Common Stock A-Award	Haas Kevin Richard Chief Technology Officer	Officer	23 697 Value: $129.6K
Jan 01, 2026 Sell	Common Stock F-InKind	Muzzey Dale Chief Scientific Officer	Officer	418 Value: $3K
Dec 25, 2025 Sell	Common Stock F-InKind	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	21 Value: $138
Dec 11, 2025 Sell	Common Stock F-InKind	Raha Samraat S. President And CEO	CEO / President	29 634 Value: $216.3K
Nov 03, 2025 Buy	Common Stock J-Other	Ancona Margaret Officer	Officer	0 Value: $0
Oct 24, 2025 Buy	Common Stock J-Other	Munk Natalie Officer	Officer	0 Value: $0
Sep 21, 2025 Sell	Common Stock F-InKind	Verratti Mark Chief Operating Officer	C-Suite Officer	1 085 Value: $8K
Sep 21, 2025 Sell	Common Stock F-InKind	Munk Natalie Chief Accounting Officer	Officer	962 Value: $7K
Sep 21, 2025 Sell	Common Stock F-InKind	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	2 559 Value: $19.9K
Sep 21, 2025 Sell	Common Stock F-InKind	Ancona Margaret EVP, Strategy & Transformation	Officer	958 Value: $7K
Sep 21, 2025 Sell	Common Stock F-InKind	Ancona Margaret EVP, Strategy & Transformation	Officer	958 Value: $7K
Sep 21, 2025 Sell	Common Stock F-InKind	Wheeler Benjamin Richard Chief Financial Officer	C-Suite Officer	2 559 Value: $19.9K
Sep 21, 2025 Sell	Common Stock F-InKind	Munk Natalie Chief Accounting Officer	Officer	962 Value: $7K
Sep 21, 2025 Sell	Common Stock F-InKind	Verratti Mark Chief Operating Officer	C-Suite Officer	1 085 Value: $8K
Sep 03, 2025 Sell	Common Stock F-InKind	Fox Jennifer Lynne Chief Legal Officer	Officer	4 435 Value: $30.2K
Sep 03, 2025 Sell	Common Stock F-InKind	Fox Jennifer Lynne Chief Legal Officer	Officer	4 435 Value: $30.2K
Aug 18, 2025 Buy	Common Stock J-Other	Leffler Scott J. Officer	Officer	0 Value: $0
Aug 18, 2025 Buy	Common Stock J-Other	Leffler Scott J. Officer	Officer	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MYRIAD GENETICS

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing...

Read Full Profile Here